/Companies

Dxcover

9 known investors

Find your way into Dxcover

Sign up to see every warm intro you have to Dxcover

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Dxcover team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Dxcover provides a platform for rapid development of liquid biopsies to detect cancer and other diseases.

Investors · 9

Also in the syndicate · 4

Macmillan Cancer SupportNorcliffe CapitalleadSIS VenturesleadUniversity of Strathclydelead

Funding

SEC filings, press & company announcements

$6.2M disclosed across 1 of 2 rounds · 2023–2025

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 7

EarlydxEarlyDx develops non-invasive liquid biopsy tests aimed at early cancer detection and precision medicine. The company positions its tests as accurate and affordable diagnostics.
Foresight DiagnosticsForesight Diagnostics develops ultra-sensitive molecular diagnostic tests that combine genomics and bioinformatics to detect minimal residual disease and circulating tumor DNA across multiple cancer types. Its offerings support oncology drug development, clinical trials, and patient care for academic and biopharma partners.
Digital DiagnosticsDigital Diagnostics is a healthcare technology company that builds AI systems to diagnose disease by analyzing medical images. Its flagship system diagnoses diabetes-related eye disease at the point of care without requiring a physician to review the images, serving primary and specialty care providers.
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Smarter DxSmarterDx provides a clinical AI platform that helps hospitals and health systems improve documentation, coding, and revenue cycle management by accurately capturing the complexity of patient care. The platform assists health systems in recovering revenue, improving quality scores, and streamlining workflows across the revenue cycle.
Pink DxPinkDx is a diagnostics company developing tests, led by a leadership team spanning scientific, medical, and business functions.
CareDxCareDx provides innovative solutions and diagnostic tools for transplant patients throughout their pre- and post-transplant journey to improve outcomes and equity in organ transplantation.

Companies working in the same space as Dxcover.

In the news

Frequently asked questions

What does Dxcover do?
Dxcover provides a platform for rapid development of liquid biopsies to detect cancer and other diseases.
Who are Dxcover's investors?
Dxcover's investors include Eos Advisory, Scottish Enterprise, Alba Equity, British Business Bank, Maven Capital Partners.
How much funding has Dxcover raised?
Dxcover has disclosed $6.2M raised across 1 of its 2 known rounds.